Sentynl Therapeutics’ Nulibry (fosdenopterin) Gains the MHRA’s Approval to Treat Molybdenum Cofactor Deficiency (MoCD) Type A
Shots: The MHRA has approved Sentynl’s (wholly-owned by Zydus Lifesciences)...
NovelMed’s NM5072 Receives the US FDA’s Orphan Drug Designation to Treat Paroxysmal Nocturnal Hemoglobinuria (PNH)
Shots: The US FDA has granted orphan drug designation to the company’s NM507...
The US FDA Accepts GSK’s BLA of Meningococcal ABCWY Vaccine for Invasive Meningococcal Disease (IMD)
Shots: The US FDA has accepted the BLA of 5-in-1 meningococcal ABCWY (MenABCWY) va...
The US FDA Grants Orphan Drug Designation to Candel Therapeutics’ CAN-2409 as a Treatment for Pancreatic Cancer
Shots: The company’s CAN-2409 has received the US FDA’s orphan drug de...
PureTech’s LYT-200 Gains the US FDA’s Fast Track Designation for Treating Head and Neck Cancers
Shots: The US FDA has granted FTD to LYT-200, human IgG4 mAb targeting galectin-9,...
AstraZeneca and Daiichi Sankyo’s Enhertu Receives the US FDA’s Accelerated Approval to Treat Metastatic HER2-Positive Solid Tumors
Shots: The approval was supported by 3 P-II studies assessing the safety & eff...
